Found 28 matching trials
Study of PF 04965842 Effect on MATE1/2K Activity in Healthy Participants PHASE1 This is a Phase 1, randomized, 2 way crossover, open label study of the eff...
Show More Location
Pfizer Clinical Research Unit
Learn More & Join Trial
JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis PHASE3 This is a randomized, double blind, placebo controlled, parallel group, Pha...
Show More Location
Clinical Research Center of Alabama, LLC
Learn More & Join Trial
Study to Assess Pharmacokinetics, Safety and Tolerability of PF-04965842 in Chinese Healthy Participants PHASE1 The purpose of this study is to assess the pharmacokinetics, safety and tol...
Show More Location
Beijing Hospital Sub-Center of Beijing Hospital Clinical Trial & Research Center
Learn More & Join Trial
A Hepatic Impairment Study for PF-04965842. PHASE1 This is a Phase 1 non randomized, open label, single dose, parallel cohort ...
Show More Location
Orlando Clinical Research Center
Learn More & Join Trial
Absorption, Metabolism, Excretion and Absolute Bioavailability PHASE1 This study will investigate the absorption, metabolism and excretion of 14C...
Show More Location
PRA Health Sciences
Learn More & Join Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis PHASE3 B7451015 is a Phase 3 study to evaluate Abrocitinib with or without Topical...
Show More Location
Total Skin and Beauty Dermatology Center, PC
Learn More & Join Trial
A Study to Determine the Effects of PF-04965842 on Midazolam PK in Healthy Volunteers PHASE1 This is a Phase 1, randomized, 2-way crossover, multiple dose, open label s...
Show More Location
Pfizer Clinical Research Unit
Learn More & Join Trial
Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis PHASE2 Study B7451006 is a Phase 2b POC study which is planned to assess four PF 0...
Show More Location
Clinical Research Center of Alabama
Learn More & Join Trial
Pre-approval Single-patient Expanded Access for Abrocitinib (PF-04965842) N/A Provide pre-approval single patient Expanded Access (compassionate use) of ...
Show More Location
Multiple Locations
Learn More & Join Trial
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis PHASE2 Study B7451005 is a Phase 2 study which will assess the efficacy and safety...
Show More Location
Total Skin and Beauty Dermatology Center, PC
Learn More & Join Trial